Summary
The effects of nefiracetam [DM-9384; N-(2, 6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide], a cognitive enhancer, on extracellular acetylcholine and glutamic acid in the frontal cortex were studied using brain microdialysis in freely moving rats. Nefiracetam administration (1 mg/kg, p.o.) doubled the amount of acetylcholine in the dialysate. When tetrodotoxin was added to the perfusion solution, the basal level of acetylcholine decreased and nefiracetam caused no increase in acetylcholine outflow. The amount of glutamic acid in the dialysates was not affected by nefiracetam. These results suggest that nefiracetam increases the amount of acetylcholine within the cholinergic synaptic clefts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abe E (1991) Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain. Psychopharmacology 105: 310–316
Ajima A, Kato T (1988) Brain dialysis: detection of acetylcholine release in the striatum, hippocampus and frontal cortex of freely moving rats. Biogenic Amines 5: 461–464
Allison LA, Mayer GS, Shoup RE (1984)o-Phthalaldehyde derivates of amines for highspeed liquid chromatography/electrochemistry. Anal Chem 56: 1089–1096
Fujimori K, Yamamoto K (1987) Determination of acetylcholine and choline in perchlorate extracts of brain tissue using liquid chromatography-electrochemistry with an immobilized-enzyme reactor. J Chromatogr 414: 167–173
Giovannini MG, Casamenti F, Nistri A, Paoli F, Pepeu G (1991) Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis. Br J Pharmacol 102: 363–368
Greenamyre JT, Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Ag 10: 593–602
Izquierdo I (1991) Role of NMDA receptors in memory. Trends Pharmacol Sci 12: 128–129
Kojima H, Kawajiri S, Sakurai T, Yamasaki T (1990) Effect of DM-9384, a new pyrrolidone derivative, on passive avoidance and cerebral choline acetyltransferase activity in rats. In: Nagatsu T, Fisher A, Yoshida M (eds) Basic, clinical and therapeutic aspects of Alzheimer's and Parkinson's diseases, vol 2. Plenum Press, New York, pp 367–370
Kosaka T, Yamanishi Y, Ogura H, Yamatsu K (1990) Effects of E2020 on the extracellular level of acetylcholine in the rat cerebral cortex measured by microdialysis without addition of cholinesterase inhibitor. Eur J Pharmacol 183: 1936
Krogsgaard-Larsen P, Lund TM, Jorgensen FS, Brehm L (1991) Excitatory amino acid receptors: Multiplicity and structural requirements for activation and blockade. In: Wheal HV, Thomson AM (eds) Excitatory amino acid and synaptic transmission. Academic Press, London, pp 1–17
Kurokawa M, Mori A, Shiozaki S, Kanda T, Yoshizaki R, Ishii A (1992) Effects of KW-6055, a novel benzylpyridine derivate, on central cholinergic systems. Folia Pharmacol Jpn 99: 435–443
Levy A, Roberto KM, Michael SJ, Shukitt-Hale B, Kadar T, Rauch TM, Lieberman HR (1991) Nimodipine improves spatial working memory and elevates hippocampal acetylcholine in young rats. Pharmacol Biochem Behav 39: 781–786
Nabeshima T, Noda Y, Tohyama K, Itoh J, Kameyama T (1990) Effects of DM-9384 in a model of amnesia based on animals with GABAergic neuronal dysfunctions. Eur J Pharmacol 178: 143–149
Nabeshima T, Tohyama K, Murase K, Ishihara S, Kameyama T, Yamasaki T, Hatanaka S, Kojima H, Sakurai T, Takasu Y, Shiotani T (1991) Effects of DM-9384, a cyclic derivative of GABA, on amnesia and decreases in GABAA and muscarinic receptors induced by cycloheximide. J Pharmacol Exp Ther 257: 271–275
Ogane N, Takada Y, Iga Y, Kawanishi G, Mizobe F (1990) Effects of a Ml muscarinic receptor agonist on the central cholinergic system, evaluated by brain microdialysis. Neurosci Lett 114: 95–100
Sakurai T, Ojima H, Yamasaki T, Kojima H, Akashi A (1989) Effects of N-(2, 6-dimethylphenyl)-2-(2-oxo-l-pyrrolidinyl)acetamide (DM-9384) on learning and memory in rats. Jpn J Pharmacol 50: 47–53
Sarter M (1991) Taking stock of cognition enhancers. Trends Pharmacol Sci 12: 456–461
Sigala S, Imperato A, Rizzonelli P, Casolini P, Missale C, Spano P-F (1992) L-α-glyceryl-phosphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat. Eur J Pharmacol 211: 351–358
Stanley EF (1993) Single calcium channels and acetylcholine release at a presynaptic nerve terminal. Neuron 11: 1007–1011
Toide K, Arima T (1989) Effects of cholinergic drugs on extracellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis. Eur J Pharmacol 173: 133–141
Watabe S, Yamaguchi H, Ashida S (1990) Effects of DM-9384, a new cognition-enhancing agent, on cholinergic system in rat cortex. Soc Neurosci Abstr 16: 137
Watabe S, Yamaguchi H, Ashida S (1993) DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex. Eur J Pharmacol 238: 303–309
Yoshii M, Watabe S (1994) Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells. Brain Res 642: 123–131
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kawajiri, S., Taniguchi, K., Sakurai, T. et al. Nefiracetam enhances acetylcholine outflow from the frontal cortex: in vivo microdialysis study in the rat. J. Neural Transmission 98, 15–22 (1994). https://doi.org/10.1007/BF01277591
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01277591